FindTrial
Sign In

Estimation of fractional excretion of uric acid among type 2 diabetes mellitus patients on SGLT2 inhibitors

Fractional excretion of uric acid among type 2 Diabetic Mellitus patients on SGLT2 inhibitors A Prospective Comparative study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087533
Enrollment
28
Registered
2025-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Prabhakar Kore hospital and MRC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with type2 diabetes aged 18-65 years irrespective of gender attending OPD who are eligible for SGLT2 inhibitor treatment will be included in the study

Exclusion criteria

Exclusion criteria: Patients on uricosuric drugs like Losartan Diuretics and Probenecid Type 1 diabetes mellitus patients

Design outcomes

Primary

MeasureTime frame
The results of the study might help in the treatment of Diabetes Mellitus patients with hyperuricemiaTimepoint: 3 months—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactRakshita Bhajanthri

JNMC

rakshita.b9991@gmail.com08861425296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026